Enzolytics Inc (ENZC)

[falon]

Sooner than later.

I hope the study is started by March, if not sooner and be done by June/July if product is available.

I believe the hold up is lack of product.

It takes time to make monoclonal antibodies.

The only definitive date we have from REGN is from the infamous slide #27:

On slide #27, the Company stated its 'Next-gen COVID antibody binds outside variable RBD and has demonstrated high neutralization activity against all known variants and lineages and disclosed it anticipates initiating the REGN14287 phase 3 clinical trial in 2023, pending regulatory discussions.

I suspect the share price will be going a wild ride and with all the irons ENZC have in the fire it is no telling WHERE the ride will END.